Posterior capsule opacification: a cell biological perspective.
about
Does a small central Nd:YAG posterior capsulotomy improve peripheral fundal visualisation for the vitreoretinal surgeon?Aging and age-related diseases of the ocular lens and vitreous bodyThe influence of posterior capsule opacification on scanning laser polarimetry.Temporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation.Sulforaphane promotes ER stress, autophagy, and cell death: implications for cataract surgeryLong noncoding RNA expression profile in HLE B-3 cells during TGF-β2-induced epithelial-mesenchymal transition.Suppression of injury-induced epithelial-mesenchymal transition in a mouse lens epithelium lacking tenascin-CADAM and ADAMTS gene expression in native and wound healing human lens epithelial cellsAn Overview of Nd:YAG Laser CapsulotomyMicropatterned Protective Membranes Inhibit Lens Epithelial Cell Migration in Posterior Capsule Opacification Model.Aldose Reductase Mediates Transforming Growth Factor β2 (TGF-β2)-Induced Migration and Epithelial-To-Mesenchymal Transition of Lens-Derived Epithelial Cells.Effect of NF-κB p65 antisense oligodeoxynucleotide on transdifferentiation of normal human lens epithelial cells induced by transforming growth factor-β2In Vitro Evaluation of the Effects of Intraocular Lens Material on Lens Epithelial Cell Proliferation, Migration, and Transformation.Melatonin Reduces Cataract Formation and Aldose Reductase Activity in Lenses of Streptozotocin-induced Diabetic Rat.Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status.Sprouty is a negative regulator of transforming growth factor β-induced epithelial-to-mesenchymal transition and cataract.Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation.Effect of haptic material and number of intraocular lens on anterior capsule contraction after cataract surgery.Elevated Transforming Growth Factor-β2 in the Aqueous Humor: A Possible Explanation for High Rate of Capsular Contraction Syndrome in High Myopia.Elevated tropomyosin expression is associated with epithelial-mesenchymal transition of lens epithelial cells.Nitric oxide, a survival factor for lens epithelial cells.Nuclear translocation of myocardin-related transcription factor-A during transforming growth factor beta-induced epithelial to mesenchymal transition of lens epithelial cells.αB-crystallin is essential for the TGF-β2-mediated epithelial to mesenchymal transition of lens epithelial cellsTGFbeta promotes Wnt expression during cataract developmentPrevention of posterior capsular opacification through cyclooxygenase-2 inhibition.FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.The lens as a model for fibrotic disease.Post-operative capsular opacification: a review.The lens equator: a platform for molecular machinery that regulates the switch from cell proliferation to differentiation in the vertebrate lens.Matrix metalloproteinase inhibitors: a patent review (2011 - 2013).Reduced glutathione level promotes epithelial-mesenchymal transition in lens epithelial cells via a Wnt/β-catenin-mediated pathway: relevance for cataract therapy.EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model.Zinc chloride inhibits human lens epithelial cell migration and proliferation involved in TGF-β1 and TNF-α signaling pathways in HLE B-3 cells.Type I collagen accelerates the spreading of lens epithelial cells through the expression and activation of matrix metalloproteinases.RNA Interference Targeting Snail Inhibits the Transforming Growth Factor β 2-Induced Epithelial-Mesenchymal Transition in Human Lens Epithelial Cells.Fast in situ enzymatic gelation of PPO-PEO block copolymer for injectable intraocular lens in vivo.EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.EGFR-blockade with erlotinib reduces EGF and TGF-β2 expression and the actin-cytoskeleton which influences different aspects of cellular migration in lens epithelial cells.Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal.Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium.
P2860
Q24801933-B584F795-365B-4FEC-8962-E61500488795Q26828962-3E8695EA-86B7-4458-8645-1895DCE957A4Q33239194-DCB03937-78A0-4ACF-BC66-E2AB012DEE05Q33371165-5BDDB750-BD23-48A1-8BA6-81D763D2291AQ33600014-EC7A705A-C13D-427E-BC1E-EE72B4050548Q33696760-3F10AC26-88F4-4489-AC5F-3FD577F98FEFQ33980575-ADD1D90D-002B-4FDE-98B2-1DF6F5920D85Q34434205-6B65D36E-A1EE-42BD-8F4F-79106309CF89Q35138283-E2459D5E-DC91-4801-BDD0-34E30DB9A931Q35229151-FAB426D5-1FB5-4409-A26D-F587DB9867D4Q35831260-3CCE5969-26E9-4153-AF0B-1E8E3B65969DQ35947489-783D9881-D954-451B-A253-1A8CDAF9EA99Q36061018-118D422E-9410-4B26-9DF0-6E32636334E2Q36065544-FA93881C-7DFD-4EAF-ABE7-BF90FF6004FCQ36088042-E0A3954F-8795-4647-9B1E-55F17BB061C4Q36130909-F8083FEC-9266-4923-AD24-302D24B308F2Q36155010-9DEA9BFB-F8F5-4BA7-9573-12562F3FB6D0Q36549200-61E8A47A-93EA-4909-85BA-675967F08BB6Q36569022-D50F7225-7A17-4A17-A0C4-772957C06A23Q36576024-8B5E3BFF-9FA9-4890-A5E4-5EDF22B32688Q36691924-49D6EB72-88A5-4A46-90DB-1E8BA91770C2Q36846663-094474E8-2714-4C9F-8760-5A57E0374CA6Q37056054-DC3CB83D-6420-4E93-B726-39947D2711D2Q37195207-355A7BF4-D55D-4AB4-AAC6-D616B6E886CEQ37395621-9C7F8C3C-2DFD-454D-9900-9A8EA7486E68Q37747461-BB598F3E-EFAD-4097-B47A-0672E8F2321FQ37852901-CE98FEE1-0676-4E55-80C7-60D1241F383AQ38106963-94C0913E-C1EE-4517-9CD1-E7F6E4060573Q38203588-7526BE27-5142-47B8-BB24-5BE3492E2E06Q38237471-F95B6B53-B8AE-43DB-BD12-1CDB47C089F6Q38615625-4DBC317A-4DE8-4D25-9306-DADC6542DBEAQ38932568-F86BAC3F-471C-42C2-849E-4452F8464672Q39002224-FB7EE414-E9D9-46C5-B411-E680FC4B341CQ39036479-03DDCCDD-5327-495D-9510-D7AB4F106202Q39069835-DE6ECC88-D98A-487B-9EA5-81F9B368556DQ39094000-DC6AA071-F395-4964-BAD5-5BF82799427CQ39208743-63EF239A-DAC7-455E-A7FA-698CE45586AEQ39240787-A7DEE27A-AF44-4D53-ABB3-F733B699C5BCQ40178093-473C2A7F-4534-4B2C-85E3-BB4219826AE1Q40185259-13D2DFC7-2BE5-4A4D-A80A-32C76730F4DE
P2860
Posterior capsule opacification: a cell biological perspective.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Posterior capsule opacification: a cell biological perspective.
@ast
Posterior capsule opacification: a cell biological perspective.
@en
Posterior capsule opacification: a cell biological perspective.
@nl
type
label
Posterior capsule opacification: a cell biological perspective.
@ast
Posterior capsule opacification: a cell biological perspective.
@en
Posterior capsule opacification: a cell biological perspective.
@nl
prefLabel
Posterior capsule opacification: a cell biological perspective.
@ast
Posterior capsule opacification: a cell biological perspective.
@en
Posterior capsule opacification: a cell biological perspective.
@nl
P356
P1476
Posterior capsule opacification: a cell biological perspective
@en
P2093
I Michael Wormstone
P304
P356
10.1006/EXER.2001.1153
P577
2002-03-01T00:00:00Z